Psyence BioMed Ltd. is developing ibogaine for clinical research, filing an IND application, and accelerating development via executive action.
6 reports, 2 independent
Updated Aug 19
Gone quiet
Reached 6 outlets in its first 24 hours
- Reports
- 6
- Developments
- 1
- Repetition
- 83%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Psyence BioMed Ltd. is developing ibogaine for clinical research, filing an IND application, and accelerating development via executive action.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
University of Miami
private university in Coral Gables, Florida, United States
Nothing else this week.
- FDA
-
Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)